181 related articles for article (PubMed ID: 15662845)
1. NMDA receptor in nucleus accumbens is implicated in morphine withdrawal in rats.
Ji D; Sui ZY; Ma YY; Luo F; Cui CL; Han JS
Neurochem Res; 2004 Nov; 29(11):2113-20. PubMed ID: 15662845
[TBL] [Abstract][Full Text] [Related]
2. Ionotropic glutamatergic neurotransmission in the ventral tegmental area modulates DeltaFosB expression in the nucleus accumbens and abstinence syndrome in morphine withdrawal rats.
Wang HL; Xiang XH; Guo Y; Wu WR; Cao DY; Wang HS; Zhao Y
Eur J Pharmacol; 2005 Dec; 527(1-3):94-104. PubMed ID: 16303124
[TBL] [Abstract][Full Text] [Related]
3. Involvement of glutamate receptors within the central nucleus of the amygdala in naloxone-precipitated morphine withdrawal-induced conditioned place aversion in rats.
Watanabe T; Nakagawa T; Yamamoto R; Maeda A; Minami M; Satoh M
Jpn J Pharmacol; 2002 Apr; 88(4):399-406. PubMed ID: 12046982
[TBL] [Abstract][Full Text] [Related]
4. Rapid neuroadaptation in the nucleus accumbens and bed nucleus of the stria terminalis mediates suppression of operant responding during withdrawal from acute opioid dependence.
Criner SH; Liu J; Schulteis G
Neuroscience; 2007 Feb; 144(4):1436-46. PubMed ID: 17161915
[TBL] [Abstract][Full Text] [Related]
5. Nitric oxide synthase inhibitors attenuate acute and chronic morphine withdrawal response in the rat locus coeruleus: an in vivo voltammetric study.
Hall S; Milne B; Jhamandas K
Brain Res; 1996 Nov; 739(1-2):182-91. PubMed ID: 8955938
[TBL] [Abstract][Full Text] [Related]
6. Antinociceptive potentiation and attenuation of tolerance by intrathecal co-infusion of magnesium sulfate and morphine in rats.
McCarthy RJ; Kroin JS; Tuman KJ; Penn RD; Ivankovich AD
Anesth Analg; 1998 Apr; 86(4):830-6. PubMed ID: 9539610
[TBL] [Abstract][Full Text] [Related]
7. The effect of the glycine/NMDA receptor antagonist, (+)-HA966, on morphine dependence in neuropathic rats.
Christensen D; Guilbaud G; Kayser V
Neuropharmacology; 2000 Jul; 39(9):1589-95. PubMed ID: 10854903
[TBL] [Abstract][Full Text] [Related]
8. Suppression of acute and chronic opioid withdrawal by a selective soluble guanylyl cyclase inhibitor.
Sullivan ME; Hall SR; Milne B; Jhamandas K
Brain Res; 2000 Mar; 859(1):45-56. PubMed ID: 10720614
[TBL] [Abstract][Full Text] [Related]
9. Protein kinases in the rat nucleus accumbens are involved in the aversive component of opiate withdrawal.
Valverde O; Tzavara E; Hanoune J; Roques BP; Maldonado R
Eur J Neurosci; 1996 Dec; 8(12):2671-8. PubMed ID: 8996817
[TBL] [Abstract][Full Text] [Related]
10. Effect of glutamate receptor antagonists microinjected into the nucleus accumbens on place aversion induced by naloxone in single-dose, morphine-treated rats.
Kawasaki Y; Ishida S; Jin C; Kitamura Y; Kawasaki H; Gomita Y; Sendo T; Araki H
Eur J Pharmacol; 2011 Sep; 666(1-3):131-4. PubMed ID: 21635886
[TBL] [Abstract][Full Text] [Related]
11. Oleoyl glycine: interference with the aversive effects of acute naloxone-precipitated MWD, but not morphine reward, in male Sprague-Dawley rats.
Petrie GN; Wills KL; Piscitelli F; Smoum R; Limebeer CL; Rock EM; Humphrey AE; Sheppard-Perkins M; Lichtman AH; Mechoulam R; Di Marzo V; Parker LA
Psychopharmacology (Berl); 2019 Sep; 236(9):2623-2633. PubMed ID: 30993360
[TBL] [Abstract][Full Text] [Related]
12. Spinal kappa-opioid system plays an important role in suppressing morphine withdrawal syndrome in the rat.
Cui CL; Wu LZ; Han JS
Neurosci Lett; 2000 Dec; 295(1-2):45-8. PubMed ID: 11078933
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of reinforcing effects of morphine and naloxone-precipitated opioid withdrawal by novel glycine site and uncompetitive NMDA receptor antagonists.
Popik P; Mamczarz J; Fraczek M; Widła M; Hesselink M; Danysz W
Neuropharmacology; 1998 Aug; 37(8):1033-42. PubMed ID: 9833632
[TBL] [Abstract][Full Text] [Related]
14. Effects of Injection of Gamma-Aminobutyric Acid Agonists into the Nucleus Accumbens on Naloxone-Induced Morphine Withdrawal.
Topkara B; Yananli HR; Sakallı E; Demirkapu MJ
Pharmacology; 2017; 100(3-4):131-138. PubMed ID: 28637045
[TBL] [Abstract][Full Text] [Related]
15. Role of corticotropin-releasing hormone in the amygdala and bed nucleus of the stria terminalis in the behavioral, pain modulatory, and endocrine consequences of opiate withdrawal.
McNally GP; Akil H
Neuroscience; 2002; 112(3):605-17. PubMed ID: 12074902
[TBL] [Abstract][Full Text] [Related]
16. Mu- and delta-opioid receptor antagonists precipitate similar withdrawal phenomena in butorphanol and morphine dependence.
Feng YZ; Zhang T; Tokuyama S; Zhu H; Rockhold RW; Ho IK
Neurochem Res; 1996 Jan; 21(1):63-71. PubMed ID: 8833225
[TBL] [Abstract][Full Text] [Related]
17. Attenuation of acute morphine withdrawal in the neonatal rat by the competitive NMDA receptor antagonist LY235959.
Jones KL; Zhu H; Jenab S; Du T; Inturrisi CE; Barr GA
Neuropsychopharmacology; 2002 Mar; 26(3):301-10. PubMed ID: 11850145
[TBL] [Abstract][Full Text] [Related]
18. Focal kappa-opioid receptor-mediated dependence and withdrawal in the nucleus paragigantocellularis.
Sinchaisuk S; Ho IK; Rockhold RW
Pharmacol Biochem Behav; 2002 Dec; 74(1):241-52. PubMed ID: 12376173
[TBL] [Abstract][Full Text] [Related]
19. Orexins in the midline thalamus are involved in the expression of conditioned place aversion to morphine withdrawal.
Li Y; Wang H; Qi K; Chen X; Li S; Sui N; Kirouac GJ
Physiol Behav; 2011 Jan; 102(1):42-50. PubMed ID: 20951152
[TBL] [Abstract][Full Text] [Related]
20. Double dissociation in the neural substrates of acute opiate dependence as measured by withdrawal-potentiated startle.
Harris AC; Atkinson DM; Aase DM; Gewirtz JC
Neuroscience; 2006; 139(4):1201-10. PubMed ID: 16600512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
